Skip to main content
Erschienen in: Der Ophthalmologe 3/2005

01.03.2005 | Kasuistiken

Venenastverschluss und Abduzensparese bei Protein-S-Mangel

Eine genealogische Untersuchung

verfasst von: Dr. H. M. Holak, N. H. Holak, S. Holak, S. A. Holak, S. Szymaniec

Erschienen in: Die Ophthalmologie | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hintergrund

Ein Protein-S-Mangel gehört zu einem der Risikofaktoren für Venenastverschlüsse und wird autosomal dominant vererbt.

Methode

Es wurde eine genealogische Studie über 3 Generationen einer Familie mit venösen Verschlüssen durchgeführt.

Ergebnisse

Vier Familienmitglieder litten unter Komplikationen einer Venenthrombose. In der 1. Generation verstarb 1 Patient infolge der Komplikation einer tiefen Beinvenenthrombose. In der 2. Generation erlitt die Mutter im Alter von 41 Jahren eine Venenastthrombose (Protein-S-Aktivität von 18%). Gleichzeitig entstand eine Abduzensparese, und im MRT waren multiple zerebrale Läsionen nachweisbar. In der Fluoreszenzangiographie zeigte sich das Bild einer Venenastthrombose mit Zustand nach Laserkoagulation. In der 3. Generation trat bei einer Tochter im 16. Lebensjahr nach einer Beckenvenenthrombose eine Lungenembolie auf (Protein-S-Aktivität 0%). In der Fluoreszenzangiographie war eine deutliche Venendilatation darstellbar. Eine 28-jährige Tochter mit einer Protein-S-Aktivität von 16% war asymptomatisch. In der Fluoreszenzangiographie zeigten sich jedoch Venenerweiterungen. Die Protein-C-Aktivität und APC-Resistenz-Ratio waren bei allen Familienmitgliedern im Normbereich. Die Chromosomenanalyse ergab keine morphologischen Veränderungen.

Schlussfolgerung

Ein kongenitaler Protein-S-Mangel erhöht das Risiko von Thrombosen bei Heterozygoten im jungen und mittleren Alter.
Literatur
1.
Zurück zum Zitat Abu El-Asrar AM, Al-Momem AK, Al-Amro S et al. (1996) Prothrombotic states associated with retinal venous occlusion in youg adults. Int Ophthalmol 20:197–204PubMed Abu El-Asrar AM, Al-Momem AK, Al-Amro S et al. (1996) Prothrombotic states associated with retinal venous occlusion in youg adults. Int Ophthalmol 20:197–204PubMed
2.
Zurück zum Zitat Aras S, Yilmaz G, Alpas I et al. (2001) Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations. Eur J phthalmol 11:351–355 Aras S, Yilmaz G, Alpas I et al. (2001) Retinal vein occlusion and factor V Leiden and prothrombin 20210 G:A mutations. Eur J phthalmol 11:351–355
3.
Zurück zum Zitat Bertram B, Remky A, Arend O et al. (1995) Protein C, protein S, and antithrombin III in acute ocular diseases. Germ J Ophthalmol 4:332–335 Bertram B, Remky A, Arend O et al. (1995) Protein C, protein S, and antithrombin III in acute ocular diseases. Germ J Ophthalmol 4:332–335
4.
Zurück zum Zitat Biouse V (1999) Coagulation abnormalities and their neuro-ophthalmologic manifestations. Curr Opin Ophthalmol 10:382–393PubMed Biouse V (1999) Coagulation abnormalities and their neuro-ophthalmologic manifestations. Curr Opin Ophthalmol 10:382–393PubMed
5.
Zurück zum Zitat Broekmans AW, Bertina RM, Reinalda-Poot et al. (1985) Hereditary protein S deficiency and venous thrombo-embolism: a study of three dutch families. Thromb Haemost 53:273–277PubMed Broekmans AW, Bertina RM, Reinalda-Poot et al. (1985) Hereditary protein S deficiency and venous thrombo-embolism: a study of three dutch families. Thromb Haemost 53:273–277PubMed
6.
Zurück zum Zitat Ciardella AP, Yannuzzi LA, Freund KB et al. (1998) Faktor V Leiden, activated protein C resistence, and retinal vein occlusion. Retina 18:308–315PubMed Ciardella AP, Yannuzzi LA, Freund KB et al. (1998) Faktor V Leiden, activated protein C resistence, and retinal vein occlusion. Retina 18:308–315PubMed
7.
Zurück zum Zitat Comp PC, Nixon RR, Cooper MR, Esmon CT (1984) Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082–2088PubMed Comp PC, Nixon RR, Cooper MR, Esmon CT (1984) Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest 74:2082–2088PubMed
8.
Zurück zum Zitat D’Angelo A, Vigano-d’Angelo S, Esmon CT, Comp PC (1988) Aquired deficiency of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 81:1445–1454PubMed D’Angelo A, Vigano-d’Angelo S, Esmon CT, Comp PC (1988) Aquired deficiency of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 81:1445–1454PubMed
9.
Zurück zum Zitat Dhôte R, Bachmeyer C, Horellou MH et al. (1995) Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 120:388–389PubMed Dhôte R, Bachmeyer C, Horellou MH et al. (1995) Central retinal vein thrombosis associated with resistance to activated protein C. Am J Ophthalmol 120:388–389PubMed
10.
Zurück zum Zitat Engesser L, Broekmans AW, Briet E et al. (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106:677–682PubMed Engesser L, Broekmans AW, Briet E et al. (1987) Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 106:677–682PubMed
11.
Zurück zum Zitat Faude S, Faude F, Siegemund A, Wiedemann P (1999) APC-Resistenz bei Patienten mit Zentralvenenverschluß. Ophthalmologe 96:594–599CrossRefPubMed Faude S, Faude F, Siegemund A, Wiedemann P (1999) APC-Resistenz bei Patienten mit Zentralvenenverschluß. Ophthalmologe 96:594–599CrossRefPubMed
12.
13.
Zurück zum Zitat Fujimura H, Kambayashi JI, Kato H et al. (1998) Three novel missense mutations in unrelated japanese patients with type I and type II protein S deficiency and venous thrombosis. Thromb Res 89:151–160CrossRefPubMed Fujimura H, Kambayashi JI, Kato H et al. (1998) Three novel missense mutations in unrelated japanese patients with type I and type II protein S deficiency and venous thrombosis. Thromb Res 89:151–160CrossRefPubMed
14.
Zurück zum Zitat Giri TK, Linse S, de Frutos PG et al. (2002) Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b- binding protein. J Biol Chem 277:15099–15106CrossRefPubMed Giri TK, Linse S, de Frutos PG et al. (2002) Structural requirements of anticoagulant protein S for its binding to the complement regulator C4b- binding protein. J Biol Chem 277:15099–15106CrossRefPubMed
15.
Zurück zum Zitat Girolami A, Simioni P, Lazzaro AR, Cordiano I (1989) Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reducecd total and markedly reduced free protein S): a family study. Thromb Haemost 61:144–147PubMed Girolami A, Simioni P, Lazzaro AR, Cordiano I (1989) Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reducecd total and markedly reduced free protein S): a family study. Thromb Haemost 61:144–147PubMed
16.
Zurück zum Zitat Glueck CJ, Bell H, Vadlamani L et al. (1999) Heritable thrombophilia and hypofibrinolysis: posible causes of retinal vein occlusion. Arch Ophthalmol 117:43–49PubMed Glueck CJ, Bell H, Vadlamani L et al. (1999) Heritable thrombophilia and hypofibrinolysis: posible causes of retinal vein occlusion. Arch Ophthalmol 117:43–49PubMed
17.
Zurück zum Zitat Golub BM, Sibony DA, Coller BS (1990) Protein S deficiency associated with central retinal artery occlusion. Arch Ophthalmol 108:918 Golub BM, Sibony DA, Coller BS (1990) Protein S deficiency associated with central retinal artery occlusion. Arch Ophthalmol 108:918
18.
Zurück zum Zitat Grandrille S, Borgel D, Ireland H et al. (1997) Protein S deficiency: a database of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standarisation committee of the international society on thrombosis and haemostasis. Thromb Haemost 77:1201–1214PubMed Grandrille S, Borgel D, Ireland H et al. (1997) Protein S deficiency: a database of mutations. For the plasma coagulation inhibitors subcommittee of the scientific and standarisation committee of the international society on thrombosis and haemostasis. Thromb Haemost 77:1201–1214PubMed
19.
Zurück zum Zitat Greiner K, Hafner G, Dick B et al. (1999) Retinal vascular occlusion and deficiences of the protein C pathway. Am J Ophthalmol 128:69–74PubMed Greiner K, Hafner G, Dick B et al. (1999) Retinal vascular occlusion and deficiences of the protein C pathway. Am J Ophthalmol 128:69–74PubMed
20.
Zurück zum Zitat Greiner K, Hafner G, Prellwitz W, Pfeiffer N (1999) Hereditäre Störungen des Protein-C-Systems bei Zentralarterien- and Arteriolenastverschlüssen. Klin Monatsbl Augenheilkd 215:33–36PubMed Greiner K, Hafner G, Prellwitz W, Pfeiffer N (1999) Hereditäre Störungen des Protein-C-Systems bei Zentralarterien- and Arteriolenastverschlüssen. Klin Monatsbl Augenheilkd 215:33–36PubMed
21.
Zurück zum Zitat Greven CM, Weaver RG, Owen J, Slusher MM (1991) Protein S deficiency and bilateral branch retinal artery occlusion. Ophthalmology 98:33–34PubMed Greven CM, Weaver RG, Owen J, Slusher MM (1991) Protein S deficiency and bilateral branch retinal artery occlusion. Ophthalmology 98:33–34PubMed
22.
Zurück zum Zitat Guven D, Sayinalp N, Kalayci D et al. (1999) Risk faktors in central vein occlusion and activated protein C resistance. Eur J Ophthalmol 9:43–48PubMed Guven D, Sayinalp N, Kalayci D et al. (1999) Risk faktors in central vein occlusion and activated protein C resistance. Eur J Ophthalmol 9:43–48PubMed
23.
Zurück zum Zitat Hayreh SS, Zimmerman MB, Podhajski P (2002) Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:189–196CrossRef Hayreh SS, Zimmerman MB, Podhajski P (2002) Hematologic abnormalities associated with various types of retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240:189–196CrossRef
24.
Zurück zum Zitat Holmes ZR, Bertina RM, Reitsma PH (1996) Characterisation of a large chromosomal deletion in the PROS1 gene of the patient with protein S deficiency type I using long PCR. Br J Haematol 92:986–991CrossRefPubMed Holmes ZR, Bertina RM, Reitsma PH (1996) Characterisation of a large chromosomal deletion in the PROS1 gene of the patient with protein S deficiency type I using long PCR. Br J Haematol 92:986–991CrossRefPubMed
25.
Zurück zum Zitat Iijima H, Gohdo T, Imai M, Tsukahara S (1998) Thrombin-antithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol 126:677–682PubMed Iijima H, Gohdo T, Imai M, Tsukahara S (1998) Thrombin-antithrombin III complex in acute retinal vein occlusion. Am J Ophthalmol 126:677–682PubMed
26.
Zurück zum Zitat Lahey MJ, Kearney JJ, Tunc M (2003) Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 9:385–392CrossRefPubMed Lahey MJ, Kearney JJ, Tunc M (2003) Hypercoagulable states and central retinal vein occlusion. Curr Opin Pulm Med 9:385–392CrossRefPubMed
27.
Zurück zum Zitat Lahey MJ, Tunc M, Kearney J et al. (2002) Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years old. Ophthalmology 109:126–131CrossRefPubMed Lahey MJ, Tunc M, Kearney J et al. (2002) Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years old. Ophthalmology 109:126–131CrossRefPubMed
28.
Zurück zum Zitat Larsson J, Hillarp A, Olafsdottir E, Bauer B ( 1999) Activated protein C resistance and anticoagulant proteins in young adults with central retinal vine occlusion. Acta Ophthalmol Scand 77:634–637PubMed Larsson J, Hillarp A, Olafsdottir E, Bauer B ( 1999) Activated protein C resistance and anticoagulant proteins in young adults with central retinal vine occlusion. Acta Ophthalmol Scand 77:634–637PubMed
29.
Zurück zum Zitat Lerche RC, Wilhelm C, Eifrig B, Richard G (2001) Thrombophiliefaktoren als Auslöser retinaler Gefäßverschlüsse. Ophthalmologe 98:529–534CrossRefPubMed Lerche RC, Wilhelm C, Eifrig B, Richard G (2001) Thrombophiliefaktoren als Auslöser retinaler Gefäßverschlüsse. Ophthalmologe 98:529–534CrossRefPubMed
30.
Zurück zum Zitat Leroy-Matheron C, Gouault-Heilmann M, Aiach M, Gandrille S (1998) A mutation of the active protein S gene leading to EGF1-lacking protein in a family with qualitative (type II) deficiency. Blood 91:4608–4615PubMed Leroy-Matheron C, Gouault-Heilmann M, Aiach M, Gandrille S (1998) A mutation of the active protein S gene leading to EGF1-lacking protein in a family with qualitative (type II) deficiency. Blood 91:4608–4615PubMed
31.
Zurück zum Zitat Liberti G, Bertina RM, Rosendaal FR (1999) Hormonal state rather then age influence cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency. Thromb Haemost 82:1093–1096PubMed Liberti G, Bertina RM, Rosendaal FR (1999) Hormonal state rather then age influence cut-off values of protein S: reevaluation of the thrombotic risk associated with protein S deficiency. Thromb Haemost 82:1093–1096PubMed
32.
Zurück zum Zitat Mahasandana C, Suvatte V, Marlar RA et al. (1990) Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 335:61–62CrossRef Mahasandana C, Suvatte V, Marlar RA et al. (1990) Neonatal purpura fulminans associated with homozygous protein S deficiency. Lancet 335:61–62CrossRef
33.
Zurück zum Zitat Malm J, Bennhagen R, Holmberg L, Dahlbäck B (1988) Changes in the plasma levels of vitamin K-dependent protein C and S and C4b-binding protein during pregnancy and oral contraception. Br J Haematol 68:437–443PubMed Malm J, Bennhagen R, Holmberg L, Dahlbäck B (1988) Changes in the plasma levels of vitamin K-dependent protein C and S and C4b-binding protein during pregnancy and oral contraception. Br J Haematol 68:437–443PubMed
34.
Zurück zum Zitat Martinelli I, Manucci PM, De Stefano et al. (1998) Different risk of thrombosis in four coagulation deffects associated with inherited thrombophilia: a study of 150 families. Blood 92:2353–2358PubMed Martinelli I, Manucci PM, De Stefano et al. (1998) Different risk of thrombosis in four coagulation deffects associated with inherited thrombophilia: a study of 150 families. Blood 92:2353–2358PubMed
35.
Zurück zum Zitat Pegelow CH, Ledford M, Young J, Zilleruelo G (1992) Severe protein S deficiency in a newborn. Pediatrics 89:674–676PubMed Pegelow CH, Ledford M, Young J, Zilleruelo G (1992) Severe protein S deficiency in a newborn. Pediatrics 89:674–676PubMed
36.
Zurück zum Zitat Prince HM, Thurlow PJ, Buchanan RC et al. (1995) Acquired protein S deficiency in a patient with systemic lupus erythematous causing central retinal vein thrombosis. J Clin Pathol 48:387–389PubMed Prince HM, Thurlow PJ, Buchanan RC et al. (1995) Acquired protein S deficiency in a patient with systemic lupus erythematous causing central retinal vein thrombosis. J Clin Pathol 48:387–389PubMed
37.
Zurück zum Zitat Scat Y, Morin Y, Morel C, Haut J (1995) Occlusion veineuse da la rétine et résistance à la protéine C activée. J Fr Ophthalmol 18:758–762 Scat Y, Morin Y, Morel C, Haut J (1995) Occlusion veineuse da la rétine et résistance à la protéine C activée. J Fr Ophthalmol 18:758–762
38.
Zurück zum Zitat Simmonds RE, Zöller B, Ireland H et al. (1997) Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood 89:4364–4370PubMed Simmonds RE, Zöller B, Ireland H et al. (1997) Genetic and phenotypic analysis of a large (122-member) protein S-deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes. Blood 89:4364–4370PubMed
39.
Zurück zum Zitat Talmon T, Scharf J, Mayer E et al. (1997) Retinal arterial occlusion in a child with factor V Leiden and their molabile methylene reductase mutations. Am J Ophthalmol 124:689–691PubMed Talmon T, Scharf J, Mayer E et al. (1997) Retinal arterial occlusion in a child with factor V Leiden and their molabile methylene reductase mutations. Am J Ophthalmol 124:689–691PubMed
40.
Zurück zum Zitat Takayashi H, Wada K, Hayashi S et al. (1988) Behaviour of protein S during long-term oral anticoagulant therapy. Thromb Res 51:241–245PubMed Takayashi H, Wada K, Hayashi S et al. (1988) Behaviour of protein S during long-term oral anticoagulant therapy. Thromb Res 51:241–245PubMed
41.
Zurück zum Zitat Takayashi H, Tatewaki W, Wada K, Shibata A (1989) Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and other anticoagulant therapy. Clin Chem Acta 182:195–208CrossRef Takayashi H, Tatewaki W, Wada K, Shibata A (1989) Plasma protein S in disseminated intravascular coagulation, liver disease, collagen disease, diabetes mellitus, and other anticoagulant therapy. Clin Chem Acta 182:195–208CrossRef
42.
Zurück zum Zitat Tekeli O, Gursel E, Buyurgan H (1999) Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 77:628–630PubMed Tekeli O, Gursel E, Buyurgan H (1999) Protein C, protein S and antithrombin III deficiencies in retinal vein occlusion. Acta Ophthalmol Scand 77:628–630PubMed
43.
Zurück zum Zitat Vine AK, Samama MM (1993) The role of abnormalities in the anticoagulant and fibrinolytic systems in the retinal vascular occlusions. Surv Ophthalmol 37:283–292CrossRefPubMed Vine AK, Samama MM (1993) The role of abnormalities in the anticoagulant and fibrinolytic systems in the retinal vascular occlusions. Surv Ophthalmol 37:283–292CrossRefPubMed
44.
Zurück zum Zitat Vine AK, Samama MM (1997) Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in the patients with central retinal vein occlusion. Am J Ophthalmol 124:673–676PubMed Vine AK, Samama MM (1997) Screening for resistance to activated protein C and the mutant gene for factor V:Q506 in the patients with central retinal vein occlusion. Am J Ophthalmol 124:673–676PubMed
45.
Zurück zum Zitat Williamson TH (1997) Central retinal vein occlusion: what’s the story. Br J Ophthalmol 81:689–704 Williamson TH (1997) Central retinal vein occlusion: what’s the story. Br J Ophthalmol 81:689–704
46.
Zurück zum Zitat Williamson TH, Rumley A, Lowe GDO (1996) Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 80:203–208PubMed Williamson TH, Rumley A, Lowe GDO (1996) Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study. Br J Ophthalmol 80:203–208PubMed
47.
Zurück zum Zitat Zöller B, Garcia de Frutos P, Dahlbäck B (1995) Evaluation of the relationship between protein S and binding C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 85:3524–3531PubMed Zöller B, Garcia de Frutos P, Dahlbäck B (1995) Evaluation of the relationship between protein S and binding C4b-binding protein isoforms in hereditary protein S deficiency demonstrating type I and type III deficiencies to be phenotypic variants of the same genetic disease. Blood 85:3524–3531PubMed
Metadaten
Titel
Venenastverschluss und Abduzensparese bei Protein-S-Mangel
Eine genealogische Untersuchung
verfasst von
Dr. H. M. Holak
N. H. Holak
S. Holak
S. A. Holak
S. Szymaniec
Publikationsdatum
01.03.2005
Verlag
Springer-Verlag
Erschienen in
Die Ophthalmologie / Ausgabe 3/2005
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI
https://doi.org/10.1007/s00347-004-1032-2

Weitere Artikel der Ausgabe 3/2005

Der Ophthalmologe 3/2005 Zur Ausgabe

Weiterbildung · Zertifizierte Fortbildung

Fundus hypertonicus

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.